Healthy high growth potential

Results

1506

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1506 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
CDR
zł224.101.4%-17.2%zł22.3bzł234.5643.426.9%0.4%Media
AGP
€6.96-0.1%-12.8%€125.8m€8.5725.537.8%n/aCapital Goods
COXG
€11.65-6.0%25.5%€972.3m€15.3514.424.7%n/aUtilities
688072
CN¥734.0013.8%401.0%CN¥206.6bCN¥511.08125.635.2%0.04%Semiconductors
2315
HK$40.946.2%86.1%HK$41.2bHK$62.0254.440.4%n/aPharmaceuticals & Biotech
301345
CN¥204.38-1.5%109.4%CN¥22.3bCN¥320.3524.631.5%1.5%Automobiles
300432
CN¥22.861.2%93.4%CN¥39.1bCN¥34.4077.260.7%0.4%Automobiles
002709
CN¥51.614.0%210.5%CN¥104.7bCN¥58.9336.528.6%0.5%Materials
6990
HK$415.800.1%29.1%HK$97.0bHK$547.6440.744.8%n/aPharmaceuticals & Biotech
6223
NT$6,415.00-1.1%639.9%NT$628.6bNT$7,502.73170.855.5%0.3%Semiconductors
1860
HK$12.78-7.6%92.2%HK$19.6bHK$18.2633.641.1%n/aMedia
2171
HK$15.754.9%-32.0%HK$9.4bHK$21.2264.482.1%n/aPharmaceuticals & Biotech
1729
HK$19.0519.6%172.1%HK$42.5bHK$25.0054.233.6%0.3%Capital Goods
688192
CN¥37.96-2.0%-37.6%CN¥17.7bCN¥91.3819.8105.8%n/aPharmaceuticals & Biotech
KEBNI B
SEK 1.277.5%-35.8%SEK 347.5mSEK 1.603.082.7%n/aTech
2455
NT$416.0018.2%263.3%NT$76.9bNT$398.50131.345.2%0.6%Semiconductors
MONOLITH
₹707.651.1%206.3%₹15.4b₹960.0066.837.2%n/aMaterials
543273
₹2,075.007.8%146.3%₹50.7b₹2,500.0064.453.9%n/aTransportation
002970
CN¥66.457.2%45.0%CN¥12.1bn/a37.136.5%1.5%Automobiles
688700
CN¥101.4525.0%180.6%CN¥30.2bCN¥53.67203.957.4%0.2%Capital Goods
688183
CN¥138.5012.0%196.7%CN¥114.0bCN¥146.0066.432.6%0.6%Tech
MOD
US$297.378.3%207.5%US$15.7bUS$340.86129.349.2%n/aCapital Goods
325
HK$47.30-13.0%-66.0%HK$11.7bHK$81.0016.022.7%n/aConsumer Durables
RHM
€1,203.40-0.2%-31.5%€54.9b€1,882.1053.330.8%1.0%Capital Goods
Page 1 of 42